Dr. Reddy's Laboratories Inc. Sustainability Profile
Dr. Reddy's Laboratories Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States and operates extensively across key regions including Europe, Asia, and Africa. Founded in 1984, the company has established itself as a leader in the development and manufacturing of a diverse range of pharmaceutical products, including generics, active pharmaceutical ingredients (APIs), and proprietary medicines. With a commitment to quality and innovation, Dr. Reddy's offers unique solutions that cater to various therapeutic areas, such as oncology, cardiovascular, and diabetes care. The company has achieved significant milestones, including numerous product approvals and a robust pipeline of new therapies, solidifying its market position. Renowned for its dedication to affordable healthcare, Dr. Reddy's Laboratories continues to make a meaningful impact on global health outcomes.
DitchCarbon Score
How does Dr. Reddy's Laboratories Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dr. Reddy's Laboratories Inc.'s score of 87 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dr. Reddy's Laboratories Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Dr. Reddy's Laboratories Limited, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or significant climate initiatives directly attributed to Dr. Reddy's Laboratories Inc. However, emissions data and climate strategies may be inherited from its parent company, Dr. Reddy's Laboratories Limited. This includes potential commitments to the Science Based Targets initiative (SBTi) and other climate-related frameworks, although specific targets or achievements have not been disclosed. Given the absence of direct emissions data and reduction initiatives, it is essential to monitor future disclosures from Dr. Reddy's Laboratories Limited for any updates on their climate commitments and performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 177,841,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 254,563,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Dr. Reddy's Laboratories Inc.'s Industry?
How Carbon Intensive is Dr. Reddy's Laboratories Inc.'s Location?
Dr. Reddy's Laboratories Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dr. Reddy's Laboratories Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
